152 research outputs found

    Diversity of lactic acid bacteria of the bioethanol process

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Bacteria may compete with yeast for nutrients during bioethanol production process, potentially causing economic losses. This is the first study aiming at the quantification and identification of Lactic Acid Bacteria (LAB) present in the bioethanol industrial processes in different distilleries of Brazil.</p> <p>Results</p> <p>A total of 489 LAB isolates were obtained from four distilleries in 2007 and 2008. The abundance of LAB in the fermentation tanks varied between 6.0 × 10<sup>5 </sup>and 8.9 × 10<sup>8 </sup>CFUs/mL. Crude sugar cane juice contained 7.4 × 10<sup>7 </sup>to 6.0 × 10<sup>8 </sup>LAB CFUs. Most of the LAB isolates belonged to the genus <it>Lactobacillus </it>according to rRNA operon enzyme restriction profiles. A variety of <it>Lactobacillus </it>species occurred throughout the bioethanol process, but the most frequently found species towards the end of the harvest season were <it>L. fermentum </it>and <it>L. vini</it>. The different rep-PCR patterns indicate the co-occurrence of distinct populations of the species <it>L. fermentum </it>and <it>L. vini</it>, suggesting a great intraspecific diversity. Representative isolates of both species had the ability to grow in medium containing up to 10% ethanol, suggesting selection of ethanol tolerant bacteria throughout the process.</p> <p>Conclusions</p> <p>This study served as a first survey of the LAB diversity in the bioethanol process in Brazil. The abundance and diversity of LAB suggest that they have a significant impact in the bioethanol process.</p

    Effects of Medium Chain Fatty Acid Application in Swine Feed on Porcine Epidemic Diarrhea Virus

    Get PDF
    Medium chain fatty acid (MCFA) application has been identified as a promising strategy to decrease viral pathogen transmission in swine feed. Four experiments were conducted to: 1) determine if MCFAs are effective when applied to feed both prior to and after porcine epidemic diarrhea virus (PEDV) inoculation measured by quantitative reverse transcription polymerase chain reaction (qRT-PCR), 2) evaluate the effects of varying amounts and combinations of MCFA measured by qRT-PCR, and 3) evaluate selected MCFA treatments in a bioassay. In Exp. 1, treatments were arranged in a 2 × 2 + 1 factorial with the main effects of chemical treatment (0.3% Sal CURB [Kemin Industries, Des Moines, IA] or 1% MCFA blend of 1:1:1 C6:C8:C10 [PMI, Arden Hills, MN]) and timing of chemical treatment (pre or post-inoculation with PEDV), plus a positive control (feed inoculated with PEDV and no chemical treatment). Feed was treated with the respective treatment either before or after inoculation at which point it remained at ambient temperature for 24 h and then was analyzed via qRT-PCR. The analyzed values represent cycle threshold (Ct), for which a lower number indicates greater detection of viral nucleic acid. Results demonstrated that all combinations of chemical treatment and timing increased Ct compared to the positive control (P \u3c 0.05). Additionally, treatment of feed pre-PEDV inoculation resulted in increased Ct value compared to post- inoculation treatment (P = 0.009) and Sal CURB increased Ct in comparison with 1% MCFA (P \u3c 0.0001). In Exp. 2, the chemical treatments were applied pre-inoculation and consisted of:1) positive control, 2) 0.3% Sal CURB, 3) 0.125% C6, 4) 0.25% C6, 5) 0.33% C6,6) 0.125% C8, 7) 0.25% C8, 8) 0.33% C8, 9) 0.125% C10, 10) 0.25% C10, 11) 0.33% C10, 12) 0.125% C5, 13) 0.25% C5, 14) 0.33% C5, and 15) 0.66% C5, which were analyzed via qRT-PCR. Treatment of feed with 0.33% C8 resulted in increased (P \u3c 0.05) Ct values compared to all other levels of MCFA and the positive control feed. Further, Sal CURB, 0.25% C6, 0.33% C6, all levels of C8, 0.25% C10, 0.33% C10, or 0.66% C5 all had increased Ct values compared to positive control feed (P \u3c 0.05). Increasing amounts of each individual MCFA resulted in increased Ct (P \u3c 0.045). In Exp. 3, the chemical treatments were applied pre-inoculation and consisted of: 1) positive control; 2) 0.3% Sal CURB; 3) 0.25% MCFA blend; 4) 0.375% MCFA blend; 5) 0.500% MCFA blend; 6) 0.750% MCFA blend; 7) 1.0% MCFA blend; 8) 0.125% C6 + 0.125% C8; 9) 0.25% C6 + 0.25% C8; 10) 0.33% C6 + 0.33% C8; 11) 0.125% C6 + 0.125% C10; 12) 0.25% C6 + 0.25% C10; 13) 0.33% C6 + 0.33% C10; 14) 0.125% C8 + 0.125% C10; 15) 0.25% C8 + 0.25% C10; and 16) 0.33% C8 + 0.33% C10, which were analyzed via qRT-PCR. Treating feed with Sal CURB, 0.500% blend, 0.750% blend, 1.0% blend, all levels of the C6 + C8, 0.25% C6 + 0.25% C10, 0.33% C6 + 0.33% C10, 0.25% C8 + 0.25% C10, or 0.33% C8 + 0.33% C10 resulted in increased Ct compared to the positive control (P \u3c 0.05). Lastly, in Exp. 4, feed was treated pre-inoculation with either 1) no treatment (positive control); 2) 0.3% Sal CURB; 3) 0.5% MCFA blend; or 4) 0.3% C8 and samples were analyzed via qRT-PCR and bioassay. Adding either 0.5% MCFA blend or 0.3% C8 resulted in increased Ct compared to the positive control. Further, only the positive control resulted in a positive in vivo bioassay. This set of experiments demonstrates that MCFA and Sal CURB are effective at decreasing detection of PEDV in feed both prior to and post-inoculation. Additionally, inclusion of lower levels of MCFA than previously evaluated may provide protection against PEDV transmission through feed

    Epigenetic Transcriptional Regulation of the Growth Arrest-Specific gene 1 (Gas1) in Hepatic Cell Proliferation at Mononucleosomal Resolution

    Get PDF
    BACKGROUND: Gas1 (growth arrest-specific 1) gene is known to inhibit cell proliferation in a variety of models, but its possible implication in regulating quiescence in adult tissues has not been examined to date. The knowledge of how Gas1 is regulated in quiescence may contribute to understand the deregulation occurring in neoplastic diseases. METHODOLOGY/PRINCIPAL FINDINGS: Gas1 expression has been studied in quiescent murine liver and during the naturally synchronized cell proliferation after partial hepatectomy. Chromatin immunoprecipitation at nucleosomal resolution (Nuc-ChIP) has been used to carry out the study preserving the in vivo conditions. Transcription has been assessed at real time by quantifying the presence of RNA polymerase II in coding regions (RNApol-ChIP). It has been found that Gas1 is expressed not only in quiescent liver but also at the cell cycle G(1)/S transition. The latter expression peak had not been previously reported. Two nucleosomes, flanking a nucleosome-free region, are positioned close to the transcription start site. Both nucleosomes slide in going from the active to the inactive state and vice versa. Nuc-ChIP analysis of the acquisition of histone epigenetic marks show distinctive features in both active states: H3K9ac and H3K4me2 are characteristic of transcription in G(0) and H4R3me2 in G(1)/S transition. Sequential-ChIP analysis revealed that the "repressing" mark H3K9me2 colocalize with several "activating" marks at nucleosome N-1 when Gas1 is actively transcribed suggesting a greater plasticity of epigenetic marks than proposed until now. The recruitment of chromatin-remodeling or modifying complexes also displayed distinct characteristics in quiescence and the G(1)/S transition. CONCLUSIONS/SIGNIFICANCE: The finding that Gas1 is transcribed at the G(1)/S transition suggests that the gene may exert a novel function during cell proliferation. Transcription of this gene is modulated by specific "activating" and "repressing" epigenetic marks, and by chromatin remodeling and histone modifying complexes recruitment, at specific nucleosomes in Gas1 promoter

    Two Distinct Triatoma dimidiata (Latreille, 1811) Taxa Are Found in Sympatry in Guatemala and Mexico

    Get PDF
    Approximately 10 million people are infected with Trypanosoma cruzi, the causative agent of Chagas disease, which remains the most serious parasitic disease in the Americas. Most people are infected via triatomine vectors. Transmission has been largely halted in South America in areas with predominantly domestic vectors. However, one of the main Chagas vectors in Mesoamerica, Triatoma dimidiata, poses special challenges to control due to its diversity across its large geographic range (from Mexico into northern South America), and peridomestic and sylvatic populations that repopulate houses following pesticide treatment. Recent evidence suggests T. dimidiata may be a complex of species, perhaps including cryptic species; taxonomic ambiguity which confounds control. The nuclear sequence of the internal transcribed spacer 2 (ITS2) of the ribosomal DNA and the mitochondrial cytochrome b (mt cyt b) gene were used to analyze the taxonomy of T. dimidiata from southern Mexico throughout Central America. ITS2 sequence divides T. dimidiata into four taxa. The first three are found mostly localized to specific geographic regions with some overlap: (1) southern Mexico and Guatemala (Group 2); (2) Guatemala, Honduras, El Salvador, Nicaragua, and Costa Rica (Group 1A); (3) and Panama (Group 1B). We extend ITS2 Group 1A south into Costa Rica, Group 2 into southern Guatemala and show the first information on isolates in Belize, identifying Groups 2 and 3 in that country. The fourth group (Group 3), a potential cryptic species, is dispersed across parts of Mexico, Guatemala, and Belize. We show it exists in sympatry with other groups in Peten, Guatemala, and Yucatan, Mexico. Mitochondrial cyt b data supports this putative cryptic species in sympatry with others. However, unlike the clear distinction of the remaining groups by ITS2, the remaining groups are not separated by mt cyt b. This work contributes to an understanding of the taxonomy and population subdivision of T. dimidiata, essential for designing effective control strategies

    Strong Interaction Physics at the Luminosity Frontier with 22 GeV Electrons at Jefferson Lab

    Full text link
    This document presents the initial scientific case for upgrading the Continuous Electron Beam Accelerator Facility (CEBAF) at Jefferson Lab (JLab) to 22 GeV. It is the result of a community effort, incorporating insights from a series of workshops conducted between March 2022 and April 2023. With a track record of over 25 years in delivering the world's most intense and precise multi-GeV electron beams, CEBAF's potential for a higher energy upgrade presents a unique opportunity for an innovative nuclear physics program, which seamlessly integrates a rich historical background with a promising future. The proposed physics program encompass a diverse range of investigations centered around the nonperturbative dynamics inherent in hadron structure and the exploration of strongly interacting systems. It builds upon the exceptional capabilities of CEBAF in high-luminosity operations, the availability of existing or planned Hall equipment, and recent advancements in accelerator technology. The proposed program cover various scientific topics, including Hadron Spectroscopy, Partonic Structure and Spin, Hadronization and Transverse Momentum, Spatial Structure, Mechanical Properties, Form Factors and Emergent Hadron Mass, Hadron-Quark Transition, and Nuclear Dynamics at Extreme Conditions, as well as QCD Confinement and Fundamental Symmetries. Each topic highlights the key measurements achievable at a 22 GeV CEBAF accelerator. Furthermore, this document outlines the significant physics outcomes and unique aspects of these programs that distinguish them from other existing or planned facilities. In summary, this document provides an exciting rationale for the energy upgrade of CEBAF to 22 GeV, outlining the transformative scientific potential that lies within reach, and the remarkable opportunities it offers for advancing our understanding of hadron physics and related fundamental phenomena.Comment: Updates to the list of authors; Preprint number changed from theory to experiment; Updates to sections 4 and 6, including additional figure
    • 

    corecore